How Does Perimenopausal Menorrhagia Affect Women's Quality of Life and Cognitive Function?
NCT06798584 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 240
Last updated 2025-02-13
Summary
The goal of this clinical trial is to investigate how iron status and heavy bleeding during the menopausal transition affect women's cognitive function and quality of life. The main questions it aims to answer are:
* What is the association between iron status, cognitive function, mood, quality of family relationships, and quality of life in perimenopausal women?
* How does iron repletion, via supplementation, affect cognitive function, mood, quality of family relationships, and quality of life in perimenopausal women?
The investigators will compare the effect of iron supplements to a placebo (gelatin capsule) to see if iron supplements could improve iron status, cognitive function, mood, quality of family relationships, and quality of life of iron-deficient and/or anemic women undergoing the menopausal transition.
Each participant will:
* Make 2 visits (about 2 hours each - baseline and endline) to the Clinical Research Center at Purdue
* Make a very brief visit at midpoint (about 10 minutes) for a checkup
* Take a daily study supplement or placebo for 4 months
Conditions
- Iron Deficiency Anemia Treatment
- Iron Deficiency
- Iron Deficiency (Without Anemia)
Interventions
- DIETARY_SUPPLEMENT
-
FeoSol Original Iron Supplement Tablets
325 mg of ferrous sulfate containing 65 mg of elemental iron
- DIETARY_SUPPLEMENT
-
21st Century Gelatin Capsules
600 mg
Sponsors & Collaborators
-
Purdue University
lead OTHER
Principal Investigators
-
Laura E Murray-Kolb, PhD · Purdue University
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- FEMALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2025-03-01
- Primary Completion
- 2025-12-31
- Completion
- 2025-12-31
Countries
- United States
Study Locations
More Related Trials
-
JDS-HF3.0 Supplementation on Menopause Related Quality of Life Outcomes in Postmenopausal Women
NCT07238478 ·Status: RECRUITING ·Phase: NA
-
A Study to Learn More About the Menopausal Hormone Therapies in Korea
NCT06033521 ·Status: COMPLETED
-
Examining the Impact of Phytoestrogens Supplementation on the Gene Expression, and Premenstrual Syndrome in Primenopausal Women
NCT07310485 ·Status: ENROLLING_BY_INVITATION ·Phase: NA
-
PhytoSERM to Prevent Menopause Associated Decline in Brain Metabolism and Cognition
NCT05664477 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
12-week Multi-vitamin/Mineral Supplementation on Peri-menopause Symptoms, Cognition, Sleep, and Psychological Well-being.
NCT07242430 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Estrogen Use in Protection From Cognitive Decline
NCT00097058 ·Status: COMPLETED
-
Atherosclerosis, Immune Mediated Inflammation and Hypoestrogenemia in Young Women
NCT03018366 ·Status: COMPLETED ·Phase: PHASE2
-
Midlife Cholesterol Study
NCT00361075 ·Status: COMPLETED ·Phase: PHASE4
-
PhytoSERM for Menopausal Hot Flashes and Sustained Brain Health
NCT06186531 ·Status: RECRUITING ·Phase: PHASE2
-
Bioidentical 'Natural' Hormone Evaluation in Early Menopause
NCT00302731 ·Status: TERMINATED ·Phase: PHASE2
-
Menopause Related Influences on Leukocyte Distribution, Monocyte Function and Platelet Reactivity
NCT05985447 ·Status: RECRUITING
-
Pilot Study to Investigate the Impact of an App on the Quality of Life and Symptoms of Individuals Affected by Menopause
NCT06987617 ·Status: COMPLETED ·Phase: NA
-
Phytoserms for Menopause Symptoms and Age-Associated Memory Decline
NCT01723917 ·Status: COMPLETED ·Phase: NA
-
Use of Black Cohosh and Red Clover for the Relief of Menopausal Symptoms
NCT00066144 ·Status: COMPLETED ·Phase: PHASE2
-
Health, Imaging, and Cognition Across the Menopausal Transition
NCT07021664 ·Status: NOT_YET_RECRUITING
-
Soy Isoflavonates Versus Placebo on Quality of Life in Menopausal Women
NCT06759350 ·Status: COMPLETED ·Phase: NA
-
Postmenopausal Progestins, MI and Stroke
NCT00005220 ·Status: COMPLETED
-
Hormonal Replacement Therapy and Small Artery Function
NCT00564031 ·Status: COMPLETED ·Phase: PHASE3
-
Effects of Ovarian Hormone Suppression on Vascular and Cognitive Function
NCT03112226 ·Status: COMPLETED ·Phase: NA
-
CVD Risk and Health in Postmenopausal Phytoestrogen Users
NCT00000613 ·Status: COMPLETED ·Phase: PHASE2
-
Hormone Therapy Effects on CVD Risk Factors
NCT00006313 ·Status: COMPLETED
-
Estrogen, HDL, and Coronary Heart Disease in Women
NCT00083824 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Soy Isoflavone Tablets: Effects on Sleep, Quality of Life, Symptoms and Cognitive Function in Menopausal Women
NCT01401946 ·Status: COMPLETED ·Phase: PHASE4
-
Effects of the Concentrated Extract of Soy on Coagulation Factors After Menopause
NCT00925639 ·Status: UNKNOWN ·Phase: PHASE3
-
Hormone Replacement and Neural Cardiovascular Control in Postmenopausal Women
NCT01633814 ·Status: TERMINATED ·Phase: NA